Molecular biology of head and neck cancer: risks and pathways
- PMID: 19010262
- PMCID: PMC2630967
- DOI: 10.1016/j.hoc.2008.08.007
Molecular biology of head and neck cancer: risks and pathways
Abstract
Patients present with a differential baseline risk of cancer based on normal and expected variations in genes associated with cancer. The baseline risk of developing cancer is acted on throughout life as the genome of different cells interacts with the environment in the form of exposures (eg, toxins, infections). As genetic damage is incurred throughout a lifetime (directly to DNA sequences or to the epigenome), events are set in motion to progressively disrupt normal cellular pathways toward tumorigenesis. This article attempts to characterize broad categories of genetic aberrations and pathways in a manner that might be useful for the clinician to understand the risk of developing cancer, the pathways that are disrupted, and the potential for molecular-based diagnostics.
Figures
References
-
- Brennan JA, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332(11):712–7. - PubMed
-
- Zain RB, et al. Oral lesions associated with betel quid and tobacco chewing habits. Oral Dis. 1997;3(3):204–5. - PubMed
-
- Norton SA. Betel: consumption and consequences. J Am Acad Dermatol. 1998;38(1):81–8. - PubMed
-
- Lu CT, et al. A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pathol Med. 1996;25(5):245–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
